MX349803B - Preparación farmacéutica de película que contiene sildenafil en su forma de base libre y método para producir dicha preparación. - Google Patents
Preparación farmacéutica de película que contiene sildenafil en su forma de base libre y método para producir dicha preparación.Info
- Publication number
- MX349803B MX349803B MX2013009240A MX2013009240A MX349803B MX 349803 B MX349803 B MX 349803B MX 2013009240 A MX2013009240 A MX 2013009240A MX 2013009240 A MX2013009240 A MX 2013009240A MX 349803 B MX349803 B MX 349803B
- Authority
- MX
- Mexico
- Prior art keywords
- sildenafil
- free base
- containing film
- film preparation
- producing same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Moulding By Coating Moulds (AREA)
Abstract
La presente invención se relaciona con un sistema operativo de contraseña, un aparato de contraseña, y un método generado de supercontraseña, los cuales son capaces de proteger la información de autentificación del usuario contra pirateo externo. El aparato de contraseña de la presente invención comprende uno o más procesadores, una memoria; y uno o más programas almacenados en la memoria y configurados para ser ejecutados por el o los procesadores. El programa incluye un módulo de salvaguarda de datos para almacenar datops de contraseñas para usuarios específicos; un módulo de ventana de entrada para visualizar una ventana de entrada sobre la cual se colocan varios iconos, y un módulo generador de contraseñas para verificar, cuando se seleccionen los iconos a través del módulo de ventana de entrada , la cadena de caracteres correspondientes a cada uno de los iconos seleccionados en un teclado virtual contenido en los datos de la contraseña, generado una contraseña semilla en la cual las cadenas de caracteres verificadas se combinan, y generando una supercontraseña para cada uno de los sitios web usando la contraseña semilla y un código de sitio.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20110012516 | 2011-02-11 | ||
| PCT/KR2012/001049 WO2012108738A2 (ko) | 2011-02-11 | 2012-02-13 | 실데나필 유리염기 함유 필름 제제 및 이의 제조 방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013009240A MX2013009240A (es) | 2013-08-29 |
| MX349803B true MX349803B (es) | 2017-08-14 |
Family
ID=46639094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013009240A MX349803B (es) | 2011-02-11 | 2012-02-13 | Preparación farmacéutica de película que contiene sildenafil en su forma de base libre y método para producir dicha preparación. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9907759B2 (es) |
| EP (1) | EP2674154B1 (es) |
| JP (1) | JP5973467B2 (es) |
| KR (1) | KR102010577B1 (es) |
| CN (2) | CN105250242B (es) |
| AU (1) | AU2012214939B2 (es) |
| BR (1) | BR112013020237A2 (es) |
| CA (1) | CA2827069C (es) |
| EA (2) | EA201500604A1 (es) |
| ES (1) | ES2691629T3 (es) |
| IL (1) | IL227931A (es) |
| MA (1) | MA34960B1 (es) |
| MX (1) | MX349803B (es) |
| MY (1) | MY163288A (es) |
| SG (1) | SG192284A1 (es) |
| TN (1) | TN2013000342A1 (es) |
| UA (1) | UA112540C2 (es) |
| WO (1) | WO2012108738A2 (es) |
| ZA (1) | ZA201306650B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013129889A2 (ko) | 2012-02-28 | 2013-09-06 | 주식회사 서울제약 | 실데나필을 유효성분으로 함유하며 고미가 은폐된 고함량 속용필름 |
| WO2014137189A1 (ko) * | 2013-03-07 | 2014-09-12 | 에스케이케미칼주식회사 | 고함량의 약물을 함유하는 구강 붕해 필름 및 이의 제조방법 |
| EA033893B1 (ru) * | 2013-04-11 | 2019-12-06 | СиТиСи БАЙО, ИНК. | Лекарственная форма в виде пленки, содержащей свободное основание тадалафила и полимер на основе полиэтиленгликоля и/или полимер на основе винилпирролидона в качестве агента, стабилизирующего дисперсию, раствор для получения пленки и способ получения пленки |
| US11116769B2 (en) | 2013-04-11 | 2021-09-14 | Ctc Bio, Inc. | Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer |
| CN105324111B (zh) * | 2013-05-10 | 2019-06-28 | 西梯茜生命工学股份有限公司 | 含多奈哌齐游离碱的薄膜制剂及其制备方法 |
| CN104352462A (zh) * | 2014-10-22 | 2015-02-18 | 张艳芬 | 一种提高昔多芬药物功效的方法 |
| ES2584248B1 (es) * | 2015-03-24 | 2017-04-19 | Farmalider, S.A. | Composición farmacéutica de citrato de sildenafilo en forma de suspensión para uso oral |
| AU2018253392B2 (en) | 2017-04-14 | 2023-11-02 | Capsugel Belgium Nv | Process for making pullulan |
| JP2020516653A (ja) | 2017-04-14 | 2020-06-11 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップＣａｐｓｕｇｅｌ Ｂｅｌｇｉｕｍ ＮＶ | プルランカプセル |
| CN109010324B (zh) * | 2018-08-30 | 2021-07-02 | 南京康川济医药科技有限公司 | 一种西地那非口溶膜剂及其制备方法 |
| US11179331B1 (en) | 2020-04-21 | 2021-11-23 | Cure Pharmaceutcai Holding Corp | Oral soluble film containing sildenafil citrate |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1239349A (en) * | 1983-10-10 | 1988-07-19 | Eberhard F. Gottwald | Pharmaceutical composition containing cimetidine |
| GT199900061A (es) * | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
| US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| JP4173670B2 (ja) * | 2002-03-08 | 2008-10-29 | 旭化成ファーマ株式会社 | 口腔内崩壊製剤 |
| JP5148801B2 (ja) | 2002-09-09 | 2013-02-20 | エスエス製薬株式会社 | 催眠用固形製剤 |
| FR2850275B1 (fr) * | 2003-01-24 | 2005-04-08 | Scherer Technologies Inc R P | Capsules molles a macher contenant une substance active a gout masque |
| US20050042177A1 (en) | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
| JP4547994B2 (ja) | 2004-06-02 | 2010-09-22 | 救急薬品工業株式会社 | 塊状物質含有積層フィルム状の可食性口腔内投与剤の製造方法および塊状物質含有積層フィルム状の可食性口腔内投与剤 |
| EP1845946A2 (en) | 2005-02-10 | 2007-10-24 | Orexo AB | Pharmaceutical compositions useful in the transmucosal administration of drugs |
| AU2007261567A1 (en) * | 2006-06-16 | 2007-12-27 | Tate & Lyle Ingredients Americas, Inc. | Pullulan films and their use in edible packaging |
| AU2007304425B2 (en) * | 2006-10-02 | 2013-12-05 | Spepharma Ag | Non-mucoadhesive film dosage forms |
| US20090047330A1 (en) * | 2007-08-17 | 2009-02-19 | Ramesh Bangalore | Oral fast dissolving films for erectile dysfunction bioactive agents |
| KR100920106B1 (ko) | 2007-11-14 | 2009-10-01 | 경북대학교 산학협력단 | 구연산 실데나필을 경피적으로 전달하기 위한 조절 약물전달체 및 이를 포함하는 경피 패치 |
| KR101074271B1 (ko) * | 2009-06-25 | 2011-10-17 | (주)차바이오앤디오스텍 | 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름 |
| KR20110041412A (ko) * | 2009-10-15 | 2011-04-21 | (주)씨엘팜 | Ｐｄｅ5 억제제를 함유하는 구강 용해성 필름 |
-
2012
- 2012-02-13 MY MYPI2013002963A patent/MY163288A/en unknown
- 2012-02-13 EA EA201500604A patent/EA201500604A1/ru unknown
- 2012-02-13 MX MX2013009240A patent/MX349803B/es active IP Right Grant
- 2012-02-13 US US13/984,756 patent/US9907759B2/en active Active
- 2012-02-13 SG SG2013060595A patent/SG192284A1/en unknown
- 2012-02-13 ES ES12744173.1T patent/ES2691629T3/es active Active
- 2012-02-13 EP EP12744173.1A patent/EP2674154B1/en active Active
- 2012-02-13 CA CA2827069A patent/CA2827069C/en active Active
- 2012-02-13 EA EA201391156A patent/EA027720B1/ru not_active IP Right Cessation
- 2012-02-13 WO PCT/KR2012/001049 patent/WO2012108738A2/ko active Application Filing
- 2012-02-13 KR KR1020120014086A patent/KR102010577B1/ko active IP Right Grant
- 2012-02-13 CN CN201510567618.0A patent/CN105250242B/zh active Active
- 2012-02-13 CN CN201280008427.5A patent/CN103402504B/zh active Active
- 2012-02-13 JP JP2013553372A patent/JP5973467B2/ja active Active
- 2012-02-13 AU AU2012214939A patent/AU2012214939B2/en not_active Ceased
- 2012-02-13 UA UAA201310897A patent/UA112540C2/uk unknown
- 2012-02-13 BR BR112013020237-8A patent/BR112013020237A2/pt not_active IP Right Cessation
- 2012-02-13 MA MA36227A patent/MA34960B1/fr unknown
-
2013
- 2013-08-07 TN TNP2013000342A patent/TN2013000342A1/fr unknown
- 2013-08-11 IL IL227931A patent/IL227931A/en active IP Right Grant
- 2013-09-04 ZA ZA2013/06650A patent/ZA201306650B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014505098A (ja) | 2014-02-27 |
| MY163288A (en) | 2017-08-30 |
| CA2827069C (en) | 2021-02-16 |
| AU2012214939A1 (en) | 2013-09-19 |
| UA112540C2 (uk) | 2016-09-26 |
| JP5973467B2 (ja) | 2016-08-23 |
| CN105250242A (zh) | 2016-01-20 |
| ES2691629T3 (es) | 2018-11-28 |
| IL227931A (en) | 2017-03-30 |
| MX2013009240A (es) | 2013-08-29 |
| US20130323307A1 (en) | 2013-12-05 |
| TN2013000342A1 (en) | 2015-01-20 |
| CN103402504A (zh) | 2013-11-20 |
| EA201391156A1 (ru) | 2014-02-28 |
| SG192284A1 (en) | 2013-09-30 |
| WO2012108738A3 (ko) | 2012-10-26 |
| CN105250242B (zh) | 2018-09-21 |
| WO2012108738A2 (ko) | 2012-08-16 |
| EP2674154B1 (en) | 2018-08-01 |
| IL227931A0 (en) | 2013-09-30 |
| EP2674154A2 (en) | 2013-12-18 |
| EA027720B1 (ru) | 2017-08-31 |
| CA2827069A1 (en) | 2012-08-16 |
| ZA201306650B (en) | 2015-06-24 |
| CN103402504B (zh) | 2015-10-14 |
| KR20120101301A (ko) | 2012-09-13 |
| EP2674154A4 (en) | 2015-04-01 |
| US9907759B2 (en) | 2018-03-06 |
| MA34960B1 (fr) | 2014-03-01 |
| KR102010577B1 (ko) | 2019-08-13 |
| BR112013020237A2 (pt) | 2021-03-16 |
| AU2012214939B2 (en) | 2016-11-17 |
| EA201500604A1 (ru) | 2015-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2013000342A1 (en) | Sildenafil-free base-containing film preparation and method for producing same | |
| CA143935S (en) | Reformer exercise apparatus | |
| MY186066A (en) | Anti-phf-tau antibodies and their uses | |
| MX343756B (es) | Microorganismo que produce o-fosfoserina y metodo para producir l-cisteina o derivados de la misma a partir de o-fosfoserina usando los mismos. | |
| EP2977423A4 (en) | Polishing composition, method for producing polishing composition, and kit for preparing polishing composition | |
| IN2015KN00323A (es) | ||
| TWI799741B (zh) | 用於在甲醇存在下增進還原相等物之可得性及用於產生相關之1,4－丁二醇之微生物及方法 | |
| EP2971021A4 (en) | MICROORGANISMS AND METHODS FOR PRODUCING BUTADIENE AND RELATED COMPOUNDS BY ASSIMILATING FORMAT | |
| MX369049B (es) | Aparato para producir aceros recocidos y proceso para producir dichos aceros. | |
| IN2012MU03723A (es) | ||
| NZ607149A (en) | Galacto-oligosaccharide-containing composition and a method of producing it | |
| MY161601A (en) | Films and compositions comprising the same | |
| MY156843A (en) | Silver powder and method for producing same | |
| EP2700322A4 (en) | COMPOSITION CONTAINING SCIRPUSIN B, AND PROCESS FOR PRODUCING COMPOSITION CONTAINING SCIRPUSIN B | |
| GEP201706626B (en) | Synthesis of (s)-nifuratel | |
| IN2015DN00085A (es) | ||
| MY167397A (en) | Graphite film and method for producing graphite film | |
| MX2015015377A (es) | Preparacion de pelicula que contiene donepezilo en su forma de base libre y metodo para producirla. | |
| IN2013MU01113A (es) | ||
| AU2012248013B2 (en) | Intermediate for synthesizing caspofungin and preparation method therefor | |
| IN2013CH05282A (es) | ||
| PH12015500053B1 (en) | Novel cheese and method for producing the same | |
| IN2013MU03768A (es) | ||
| IN2012CH02984A (es) | ||
| WO2012162108A9 (en) | Boron-containing compositions and methods therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |